Join UC Dec. 1 for World AIDS Day
The past, present and future of HIV/AIDS from the medical, research and urban perspective
Event Information (passed)
An estimated 40 million people worldwide have died of AIDS since 1981, and an estimated 37 million are currently living with HIV (the virus that causes AIDS), making it one of the most significant global public health issues in recorded history. First recognized in 1988, World AIDS Day is dedicated to spreading awareness of the AIDS pandemic, uniting in the fight against HIV infections and to mourning those who have died of the disease.
On Dec. 1, 2020, the University of Cincinnati will participate in Worlds AIDS Day with a symposium to highlight the past, present and future of HIV/AIDS around the world from a medical, research and urban perspective. Open to all, this day-long, virtual event will feature speakers from around the country who have endeavored in many facets of HIV/AIDS treatment, research and advocacy. The day’s speakers include:
- Judith Feinberg, M.D., chair of the HIV Medicine Association and professor of behavioral medicine & psychiatry, professor of medicine/infectious diseases and E.B. Flink Vice Chair of Medicine for Research at West Virginia University School of Medicine
- Mamie Harris, founder of IV-CHARIS (Compassionate Hearts, Assisting, Restoring, Instructing and Service), a faith-based, minority HIV organization in Cincinnati that has touched the lives of over 40,000 individuals through its collective programs
- Keith R. Green, former associate editor of Positively Aware and current chairman of the anti-AIDS group Chicago Black Gay Men’s Caucus
- Carl Fichtenbaum, M.D., professor of clinical medicine and associate chairman of medicine for translational research at the University of Cincinnati College of Medicine
- Darion Banister, regional manager for capacity building and community engagement for Gilead COMPASS Initiative located at Emory University
UC’s World AIDS Day will kick off on Nov. 30 with a workshop, "Staying Positive: Winning, Living, and Thriving with HIV," led by Morris Singletary, HIV/AIDS activist and founder of the poZItive2poSItive initiative that works to keep HIV-negative people negative, and to make sure those who are living with HIV are engaged or get re-engaged into care by initiatives that are fun and educational.
Aimed at those with HIV, the objectives of the workshop are to explain the importance of cultural humility, naming strategies for confronting HIV-related stigma, explaining different ways those living with HIV/AIDS can advocate for themselves and identifying community support and prevention services.
UC’s World AIDS Day is sponsored by the University of Cincinnati Libraries, the Office of Equity, Inclusion and Community Impact and by the Midwest AIDS Training + Education Center (MATEC). The day’s schedule, speaker bios and registration information for both the Nov. 30 workshop and the Dec. 1 symposium is available on the World AIDS Day web site.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.